1827. Genetic Characterization of Methicillin-Resistant Staphylococcus aureus (MRSA) Isolates Associated with the Development of Reduced Susceptibility to Vancomycin from Latin America

BACKGROUND: Vancomycin (VAN) is a first-line therapeutic option for severe MRSA infections, especially in Latin America where other options are limited. However, reduced susceptibility to VAN may lead to therapeutic failures. The molecular mechanisms leading the development of VAN-intermediate S. au...

Descripción completa

Detalles Bibliográficos
Autores principales: Liliana Vargas Ardila, Monica, Castro-Cardozo, Betsy E, Rios, Rafael, Hernandez, Angie K, Millan, Lina V, Carvajal, Lina P, Seas, Carlos, Munita, Jose M, Arias, Cesar A, Reyes, Jinnethe, Diaz, Lorena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6808870/
http://dx.doi.org/10.1093/ofid/ofz359.089

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6808870/
http://dx.doi.org/10.1093/ofid/ofz359.089

Ejemplares similares